Design of Single Dose Control Release Device for Antigen Delivery based on Poly (Lactic-Co- Glycolic Acid)
DOI:
https://doi.org/10.37285/ijpsn.2010.3.3.5Abstract
Vaccines are non pathogenic construct of pathogens, which exploit the ability of immune system to mount specific response against a particular pathogen, thereby protecting the host against that pathogen. The incidence of many infectious diseases have gone down considerably during last several decades as a consequence of vaccination, but successful vaccination often requires multiple immunizations. Thus the development of new vaccines, particularly the conversion of multiple dose vaccine into single dose vaccine has become an area of research. In order to be fully immunized against most infectious diseases like hepatitis B, tetanus, diphtheria, the successful administration of three doses is needed. To increase immunization coverage, to reduce excessive vaccine wastage, and to reduce the cost of immunization, vaccine in the formats other than the standard multidose formats is very much required. In the present article, we review key issues in developing single dose control release device for antigen delivery with special emphasis on design and use of poly (lactic-co- glycolic acid) or (PLGA) microparticles for controlled delivery of antigen , difficulties in encapsulating antigen inside PLGA microparticles and the various approaches which have been used successfully to encapsulate antigen inside microparticles.
Downloads
Metrics
Keywords:
Hepatitis B vaccine, PLGA Microspheres, Controlled Delivery
Downloads
Published
How to Cite
Issue
Section
References
Aguado, M. Future approaches to vaccine development: single-dose vaccines using controlled release delivery systems. Vaccine 11: 596–597 (1993).
Aguado, M., Lambert, P. Controlled release vaccines: biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles. Immunology 184: 113–125 (1992).
Alonso, MJ., Gupta, RK., Min, C., Siber, G.R., Langer, R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 12:299–306 (1994).
Anderson, JM., Shive, MS. Biodegradation and biocompatibility of PLA and PLGA microspheres, Adv. Drug Deliv. Rev. 28: 5–24 (1997).
Arshady, R. Preparation of biodegradable microspheres and microcapsules: 2.Polylactides and related polyesters. J. Contr. Rel. 17:1–22 (1991).
Brunner, A, Mader, K., Gopferich, A. pH and osmotic pressure inside biodegradable microspheres during erosion. Pharm. Res. 16: 847–853 (1999).
Carrasquillo, KG., Stanley, AM., Aponte-Carro, J. C., De Jesus, P., Costantino, H. R., Bosques, C. J., and Griebenow, K. Non-aqueous encapsulation of excipient-stabilized spray freeze dried BSA into poly (lactide-co-glycolide) microspheres results in release of native protein. J.Control.Rel. 76:199-208 (2001).
Castellanos, IJ., Crespo, R., Griebenow, K. Poly (ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. J.Control.Rel. 88:135-145 (2003).
Chang, AC., Gupta, RK. Stabilization of tetanus toxoid in poly (D, L-lactide- poly (D, L-lactic-co-glycolic acid) microspheres for the controlled release of antigen. J. Pharm. Sci. 85:129–132 (1996).
Chang, AC., Gupta, RK. Stabilization of tetanus toxoid in poly (dl-lactic-co-glycolic acid) microspheres for the controlled release of antigen. J. Pharm. Sci. 85: 129–132 (1996).
Chen, L., Apte, RN., and Cohen, S. Characterization of PLGA microspheres for the controlled delivery of IL-1a for tumor immunotherapy, J.Control.Rel. 43: 261-272 (1997).
Cho, KY., Choi Sung Ho, K., Chnag-Hyeon, N., Yoon Sung, P., Park, TG., and Park, JK. Protein release microparticles based on the blend of poly(D,L-lactic-co-glycolic acid) and oligo-ehtylene glycol grafted poly(l-lactide), J.Control.Rel. 76: 275-284 (2001).
Cleland, JL., A. Mac, B. Boyd, J. Yang, ET. Duenas, D. Yeung, D. Brooks, C. Hsu, H. Chu, Mukku, V. and Jones A. J. S. The stability of recombinant human growth hormone in poly (lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res. 14: 420-425 (1997).
Cleland, JL., Lim, A., Barro´n, L., Duenas, ET, Powell, MF. Development of a single-shot subunit vaccine for HIV-1: Part 4.Optimizing microencapsulation and pulsatile release of MN rgp120 from biodegradable .microspheres. J. Control. Release. 47: 135–150 (1997).
Cleland, JL. Single administration vaccines: controlled release technology to mimic repeated immunizations. Trends in biotechnology 17: 25-29 (1999).
Cleland, JL., Jones, A.J.S. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Pharm. Res. 13:1464–1475 (1996).
Cleland, JL, Lim, A., Barro´n, L, Duenas, ET. Powell, MF. Development of a single-shot subunit vaccine for HIV-1: Part4. Optimizing microencapsulation and pulsatile release of MN rgp120 from biodegradable microspheres, J. Controlled Rel. 47: 135–150 (1997).
Cohen, S, Yoshioka, T, Lucarelli, M, Hwang, LH., Langer, R Controlled delivery systems for proteins based on poly(lactic / glycolic acid) microspheres, Pharm. Res. 8 : 713–720.(1991).
Costantino, HR., Langer, R, and Klibanov, AM. Moisture-induced aggregation of lyophilized insulin, 11: 21-29 (1994).
Crotts, G. and Park, TG. Stability and release of bovine serum albumin encapsulated within poly(D,L-lactide-co-glycolide) microparticles. J.Control.Rel. 44:123-134 (1997).
Crotts, G, Park, G, Protein delivery from poly(lactic-coglycolic acid) biodegradable microspheres: release kinetics and stability issues. J. Microencapsul. 15: 699–713 (1998).
O’Hagan, DT, Singh M, Gupta, RK. Poly(lactide-coglycolide) microparticles for the development of single-dose controlled-release vaccines, Adv. Drug Deliv. Rev. 32 :225–246. (1998)
Debenedetti, PG., Tom, JW., Yeo, S, and Lim, GB. Application of supercritical fluids for the production of sustained delivery devices, J.Control.Rel. 24 :27-44 (1993).
Eldridge, JH., Staas, JK., Meulbroek, JA., Tice, TR., Gilley, RM., Biodegradable and biocompatible poly(dl-lactideco- glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect. Immun. 59: 2978–2986 (1991).
Ghaderi R, Sturesson C, Carlfors J. Effect of preparative parameters on the characteristics of poly(D,L-Lactide-coglycolide) microspheres made by the double emulsion methods. Int J Pharm. 141:205–216 (1996).
Ghaderi, R., Aturesson, C., Carlfors, J. Effect of preparative parameters on the characteristics of poly (D,L-lactide-co-glycolide) microspheres made by the double emulsion method, Int. J. Pharm. 141: 205–216 (1996).
Giunchedi, P, and Conte, U. Spray-drying as a preparation method of microparticulate drug delivery systems: an overview. S.T.P. Pharma Sci. 5: 276-290 (1995).
Hausberger, AG., Kenley, RA., DeLuca, PP. Gamma irradiation effects on molecular weight and in vitro degradation of poly(D,L-lactide-co-glycolide) microparticles, Pharm. Res. 12: 851–856 (1995).
Igartua, M., Hernandez, RM, Esquisabel, A., Gascon, AR., Calvo, MB, and Pedraz, JL. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems. J. Microencapsulation 14: 349-356 (1997).
Jaganathan, K.S, Singh, P., Prabakaran, D. Development of a single-dose stabilized poly (D,L-lactide-co-glycolide) miceospheres-based vaccine against hepatitis B, J. Pharm. Pharmacol. 56: 1243–1250 (2004).
Jiang, W, Schwendeman, SP. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L-lactide) and poly(ethylene glycol) microsphere blends. Pharm.Res. 18: 878-885 (2001).
Johansen, P, Men, Y, Audran, R, Corradin, G, Merkle, HP, Gander. B. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm. Res. 15:1103–1110 (1998).
Kang, F., Singh, J. Conformational stability of a model protein (bovine serum albumin) during primary emulsification process of PLGA microspheres synthesis. Int.J.Pharm. 260: 149-156 (2003).
Katakam, M, Bell, LN., and Banga, AK, Effect of Surfactants on the Physical Stability of Recombinant Human Growth Hormone, J.Pharm.Sci. 84: 713-716 (1995).
Kim, HK, Park, TG. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism, Biotechnol.Bioeng. 65: 659-667 (1999).
Krishnamurthy, R, Lumpkin, JA., Sridhar, R. Inactivation of lysozyme by sonication under conditions relevant to microencapsulation. Int.J.Pharm. 205: 23-34 (2000).
Liu, WR., Langer, R, and Klibanov, A. M. Moisture-induced aggregation of lyophilized proteins in the solid state, Biotechnol.Bioeng. 37: 177-184 (1991).
Morlock, M, Koll, H, Winter, G, and Kissel, T. Microencapsulation of rh-erythropoietin, using biodegradable poly(D, L-lactide-co-glycolide). Protein stability and the effects of stabilizing excipients, Eur.J.Pharm.Biopharm. 43: 29-36 (1997).
Nihant N, Schugens C, Grandfils C, Jerome R, Teyssie P. Polylactide microparticles prepared by double emulsion evaporation technique. I. Effect of primary emulsion stability. Pharm Res. 11: 1479–1486 (1994).
O’Hagan, DT, Jeffery, H, Roberts, MJJ., McGee, JP., and Davis, SS. Controlled release microparticles for vaccine development.Vaccine 9: 768–771 (1991b).
O’Hagan, DT., Rahman, D, McGee, JP., Jeffery, H, Davies, MC, Williams, P. Biodegradable microparticles as controlled release antigen delivery systems. Immunology 73: 239–242 (1991a).
O’Hagan, DT., Singh, M., and Gupta, RK. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines. Adv. Drug Deliv. Rev. 32: 225–246. (1997).
O’Hagan, DT., Singh,M, Gupta, RK. Poly (lactide-co-glycolide) Microparticles for the development of single-dose controlled-release vaccines. Aadvanced Drug Delivery Reviews. 32: 225-246. (1998).
Perez, C and Griebenow, K. Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres. Biotechnol.Bioeng. 82: 825-832 (2003).
Perez, C, Castellanos, IJ., Costantino, HR., Al-Azzam, W., Griebenow, K., Recent trends in stabilizing proteins structure upon encapsulation and release from bioerodible polymers. J. Pharm. Pharmacol. 54: 301–313 (2002).
Perez, C, Griebenow, K. Improved activity and stability of lysozyme at the water/CH2Cl2 interface: enzyme unfolding and aggregation and its prevention by polyols. J.Pharm.Pharmacol. 53 :1217-1226 (2001).
Pitt, C, Gratzl, MM., Aliphatic polyesters: II. The degradation of poly(DLlactide), poly (e-caprolactone) and their copolymers in vivo. Biomaterials 2: 215–220 (1981).
Pradhan, R., and Vasavada, R. Formulation and in vitro release study of ply(DLlactide) microspheres containing hydrophilic compounds, glycine and its homopeptides. J. Contr. Rel. 30: 143–154 (1994).
Sah, H. Stabilization of proteins against methylene chloride/water interface-induced denaturation and aggregation. J.Control.Rel. 58: 143-151. (1999).
Shao, PG. and Bailey, LC. Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres, Pharm.Dev.Technol. 4: 633-642. (1999).
Takada, SY. Uda, Toguchi, H., Ogawa, Y. Application of a spray drying technique in the production of TRH-containing injectable sustained-release microparticles of biodegradable polymers. PDA J. Pharm. Sci. Technol. 49: 180-184 (1995).
Van de Weert, M, Hennink, WE., and Jiskoot, W. Protein instability in poly(lactic-co-glycolic acid) microparticles, Pharm.Res. 17:159-1167 (2000).
Van de Weert, M., Hoechstetter, J, Hennink, WE., and Crommelin, DJA. The effect of a water/organic solvent interface on the structural stability of lysozyme, J.Control.Rel. 68: 351-359. (2000).
Watts, PJ, Davies, MC, Melia, CD. Microencapsulation using emulsification/ solvent evaporation: An overview of techniques and applications. Crit. Rev. Ther. Drug Carrier Syst. 7:235–259 (1990).
Witschi, C. and Doelker, E. Residual solvents in pharmaceutical products. Acceptable limits, influences on physicochemical properties, analytical methods, and documented values, Eur.J.Pharm.Biopharm. 43 : 215-242 (1997).
Yang, YY, Chung, TS, bai, XL, Chan, WK. Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chemical Engineering Science 55:2223-2236 (2000).
Zambaux MF, Bonneaux F, Gref R, Miaincent P, Dellacherie E, Alonso MJ, Labrude P, Vigneron C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release 50:31–40 (1998).
Zhu, G, Mallery, SR, and Schwendeman, SP. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nature Biotechnology 18: 52-57 (2000).
